Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Cancer Diagnosis & Prognosis|March 4, 2026
Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung CancerMinehiko Inomata, Yuki Matsushiro, Yuki Tanabe, et al.Tumori|October 25, 2014
Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapyMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.Journal of Medical Case Reports|September 6, 2012
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case reportMinehiko Inomata, Ryuji Hayashi, Kenta Kambara, et al.Cancer Reports (Hoboken, N.J.)|November 4, 2025
TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung CancerZenta Seto, Minehiko Inomata, Akira Noguchi, et al.Internal Medicine (Tokyo, Japan)|August 8, 2020
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung CancerMinehiko Inomata, Takahiro Hirai, Naoki Takata, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 ExpressionMinehiko Inomata, Naoki Takata, Isami Mizushima, et al.Anticancer Research|December 8, 2019
Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint InhibitorMinehiko Inomata, Tomonobu Kado, Seisuke Okazawa, et al.Cancer Diagnosis & Prognosis|May 9, 2022
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung CancerMinehiko Inomata, Masahiro Matsumoto, Isami Mizushima, et al.Anticancer Research|June 23, 2023
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint InhibitorsMinehiko Inomata, Masahiro Matsumoto, Kana Hayashi, et al.Scientific Reports|July 4, 2023
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancerMinehiko Inomata, Masahiro Matsumoto, Naoki Takata, et al.Pageof 4